Combined BRD4 and CDK9 inhibition as a new therapeutic approach in malignant rhabdoid tumors

Title
Combined BRD4 and CDK9 inhibition as a new therapeutic approach in malignant rhabdoid tumors
Authors
Keywords
CDK9, BRD4, rhabdoid tumors, synergistic, SMARCB1
Journal
Oncotarget
Volume 8, Issue 49, Pages -
Publisher
Impact Journals, LLC
Online
2017-06-21
DOI
10.18632/oncotarget.18583

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now